The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.
Receiving a non-melanoma skin cancer diagnosis can feel stressful. In fact, studies show that more than one in three patients find the diagnosis traumatic, with many more experiencing anxiety about what comes next. For many,…
CEO Joseph Sardano says skin cancer is often catching up with people earlier in life than it used to. Sensus Healthcare Inc. (SRTS) is marketing devices that offer some non-melanoma skin cancer (NMSC) patients an…
Local residents are opting out of surgery, and are instead undergoing a non-invasive procedure for the treatment of non-melanoma skin cancers. The SRT-100, which met standards set by the U.S. Food and Drug Administration, is…
Revenue growth of 39% marks seventh consecutive quarter of double-digit year-over-year gains Conference call begins at 4:30 Eastern time today BOCA RATON, Fla., Aug. 3, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device…
If you have patients with keloid scars on their chest, back, shoulders, earlobes, or face, you know and understand just how frustrating, annoying, and embarrassing those keloid scars can be. They’re itchy and sometimes quite…
